- Home
- RLYB vs IGTA Comparison
RLYB vs IGTA Comparison
Compare RLYB & IGTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLYB
- IGTA
- Stock Information
- Founded
- RLYB 2018
- IGTA 2021
- Country
- RLYB United States
- IGTA United States
- Employees
- RLYB N/A
- IGTA N/A
- Industry
- RLYB Biotechnology: Pharmaceutical Preparations
- IGTA Blank Checks
- Sector
- RLYB Health Care
- IGTA Finance
- Exchange
- RLYB Nasdaq
- IGTA Nasdaq
- Market Cap
- RLYB 45.2M
- IGTA 46.2M
- IPO Year
- RLYB 2021
- IGTA 2021
- Fundamental
- Price
- RLYB $0.95
- IGTA $11.08
- Analyst Decision
- RLYB Buy
- IGTA
- Analyst Count
- RLYB 6
- IGTA 0
- Target Price
- RLYB $8.10
- IGTA N/A
- AVG Volume (30 Days)
- RLYB 105.7K
- IGTA 13.9K
- Earning Date
- RLYB 11-07-2024
- IGTA 01-01-0001
- Dividend Yield
- RLYB N/A
- IGTA N/A
- EPS Growth
- RLYB N/A
- IGTA 29.68
- EPS
- RLYB N/A
- IGTA 0.12
- Revenue
- RLYB $598,000.00
- IGTA N/A
- Revenue This Year
- RLYB N/A
- IGTA N/A
- Revenue Next Year
- RLYB N/A
- IGTA N/A
- P/E Ratio
- RLYB N/A
- IGTA $99.46
- Revenue Growth
- RLYB N/A
- IGTA N/A
- 52 Week Low
- RLYB $0.93
- IGTA $10.64
- 52 Week High
- RLYB $3.46
- IGTA $12.49
- Technical
- Relative Strength Index (RSI)
- RLYB 37.53
- IGTA 39.90
- Support Level
- RLYB $0.93
- IGTA $10.52
- Resistance Level
- RLYB $1.24
- IGTA $12.00
- Average True Range (ATR)
- RLYB 0.08
- IGTA 0.24
- MACD
- RLYB -0.02
- IGTA -0.06
- Stochastic Oscillator
- RLYB 6.45
- IGTA 28.43
About RLYB Rallybio Corporation
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
About IGTA Inception Growth Acquisition Limited
Inception Growth Acquisition Ltd is a blank check company.